publication venue for
- Pulmonary and cutaneous nodules in an immunocompromised patient. 2011
- Accessory cardiac bronchus presenting with haemoptysis. 1997
- Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans. 2023
- MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. 2022
- Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.. 77. 2022
- Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis.. 77. 2021
- Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.. 75. 2020
- GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation.. 75. 2019
- Risk factors for disease progression in idiopathic pulmonary fibrosis.. 75. 2019
- Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.. 73. 2018
- Persistence of circulating endothelial microparticles in COPD despite smoking cessation.. 71. 2016
- Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.. 71. 2016
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).. 69. 2013
- Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis.. 68. 2013
- Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A.. 68. 2012
- Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.. 67. 2012
- Randomised vitamin E supplementation and risk of chronic lung disease in the Women's Health Study.. 66. 2011
- Markers of treatment failure in hospitalised community acquired pneumonia.. 63. 2008
- The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults.. 63. 2007
- Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancers.. 61. 2006
- Validation of predictive rules and indices of severity for community acquired pneumonia.. 59. 2004
- Radiological versus histological diagnosis in UIP and NSIP: survival implications.. 58. 2003
- Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment.. 48. 1993
- Bronchoalveolar lavage cell populations in bleomycin lung toxicity.. 42. 1987
- Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.. 37. 1982
- Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency.. 37. 1982
- Lung inflammation in sarcoidosis: comparison of serum angiotensin-converting enzyme levels with bronchoalveolar lavage and gallium-67 scanning assessment of the T lymphocyte alveolitis.. 37. 1982
- Ultrasound performs better than radiographs. 2010
- Pulmonary hypertension in Hodgkin's disease. 2007
- Plasma cell mucositis of the distal airways. 2005
- Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help? 2024
- Emerging biology of persistent mucous cell hyperplasia in COPD.. 74. 2018
- Reporting data on long-term follow-up of critical care trials.. 71. 2016
- Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'?. 65. 2010
- Nutritional effects on asthma aetiology and progression.. 64. 2009
- Overdiagnosis in lung cancer: different perspectives, definitions, implications.. 63. 2008
- Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification.. 60. 2005
- Non-neoplastic pulmonary lymphoid lesions. 2001
- Alveolitis: the key to the interstitial lung disorders. 1982
- Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. 2024
- Significance of the microbiome in obstructive lung disease. 2012